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www.cdatm.orgAbstractGranulomatous lobular mastitis is an unusual breast benign inflammatory disorder with unknown aetiology. It is generally
emerged with the clinical symptoms of breast mass, abscess, inflammation and mammary duct fistula. The diagnosis is made by
histopathology with a chronic non-necrotizing granulomatous inflammation in lobules of the breast tissue as the microscopic
feature. Therapy of granulomatous lobular mastitis consists of surgical, medication treatment or combination of both, but now
researches suggest that observational management is an acceptable treatment.
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Granulomatous lobular mastitis (GLM) is an un-
usual breast benign inflammatory disorder first
described by Kessler and Wolloch in 1972.1 The aeti-
ology of GLM is unknown, but growing evidences
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logic disorder, played an important role in disease
occurrence.2 The age range of GLM has been reported
from 11 to 83 years old; however it mostly emerges in
third and fourth decades women and was more
frequently reported in the Mediterranean region and
the developing countries in Asia.2 GLM closely re-
sembles the duct ectasia/periductal mastitis complex
(DE/PDM) and tuberculous mastitis in the clinical
manifestations and imaging examination.3,4 In micro-
scopic features, it is a chronic non-necrotizing granu-
lomatous inflammation in lobules of the breast tissue.5
No standard treatment exists for GLM. The main ap-
proaches are surgical, medication treatment or a com-
bination of both, but now some studies suggest that
observational management is an acceptable treatment.6
In this review, we describe the aetiology, clinical pre-
sentation, pathologic findings and differential diag-
nosis, as well as recommendations for treatment.Elsevier B.V. on behalf of KeAi Communications Co., Ltd. This is an
ons.org/licenses/by-nc-nd/4.0/).
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The aetiology ofGLM is not known exactly. Avarious
of factors, including microbiology agents, hormonal ef-
fect, and immunologic disorder have been suggested of
playing an important role in disease aetiology.
Microbiology agents
Corynebacteria are Gram-positive bacteria and
members of the skin flora. They have been found in
some patients with GLM recently and been considered
to go deeper into the breast tissue via the ductal sys-
tem. Taylor et al isolated Corynebacteria from breast
tissue in 62 patients, who were diagnosed with GLM
histologically, and 54.8% patients were bacteria-
positive. Paviour et al7 carrieded on a research of 24
patients, and observed Corynebacteria in 12 cases by
hostopathological evaluation and diagnosed 9 cases
with idiopathic granulomatous mastitis (IGM). Cory-
nebacterium kroppenstedtii was the most frequently
detected species in the studies mentioned above. In
other literature,8,9 case presentations on Corynebacte-
rium species have been mentioned as well, and species
including Corynebacterium amycolatum and Coryne-
bacterium tuberculostearicum were identified. Cory-
nebacterium accolens was also proposed as a possible
cause of GLM in a 23-year-old female.10
Hormonal effect
GLM is usually detected in women with a history of
breast-feeding or birth recently. Gestation, breast-
feeding and hyperprolactinemia have also been put for-
ward as a possible pathogenesis ofGLM.Documents and
case reports have confirmed the hypothesis aforemen-
tioned. According to a study by Bani-Hani11 et al, in the
overall cases, 16.7% had active gestation, 16.7% had an
experience of birth and breast-feeding within 6 months,
and only 8.3% did not have a history of pregnancy. In
1984, Rowe12 indicated co-morbid prolactionma in a
GLM case. Cases of GLMwith hyperprolactinemia have
also been reported in the following decades.12e14 A
relation between GLM and breastfeeding as well as the
hyperprolactinemia has been discussed but has never
been elaborated in depth. A possible cause of GLM is the
hormonal imbalance with a shift of the ratio among
gestagen and oestrogen.15 With a hypothesis of autoim-
mune reactions to extravasated secretions from lobules, it
becomesmanifest intraductally by retention of secretions
followed by ductal ectasia. The rupture of the ducts re-
sults in a persisting stromal cells inflammation.16,17Immunologic disorder
The association between GLM and erythema
nodosum and ankle arthritis have been commonly
studied recently. It has been proved that treatment with
corticosteroid and immunosuppressants is effective for
some patients, which are supported that GLM is a kind
of autoimmune disease. In the report by Zen et al,18
one patient of granulomatous mastitis was observed
with a lymphohistiocytic infiltrate, fibrosis, epithelioid
granulomas without necrosis and an infiltrate of IgG4þ
plasma cells. A conclusion of the report is that the
GLM and IgG4-related autoimmune syndrome are
possible highly correlated. Ogura et al19 reported 2
similar cases, in which an infiltrate of IgG4þ plasma
cells was also observed, and it was proposed that GLM
may consist of two subtypes: non-IgG4-related mastitis
and IgG4-related mastitis. Although the autoimmunity
of GLM has been put forward, tests for rheumatoid
factor (RF) and antinuclear antibody (ANA) are
negative in general. Ozel et al20 conducted a research
on 8 cases. In the research, 6 cases were RF positive,
and only 2 were positive for ANA and anti-double
stranded DNA. In consequence, there exists an
autuoimmne component in the aetiology of GLM.
The other factors
The other factorswhen considered about the aetiology
of GLM mainly consist of alpha-1-antitrypsin (AAT),
oral contraceptives (OCS) and smoking in general. As a
member of the serine-protease inhibitor family, AAT is
basically synthesised by hepatic cells. The deficiency of
AATcauses lung and liver pathologies primarily. In 2001,
Schelfout et al21 reported one GLM case with an AAT
deficiency.OCScould promote the breast secretion and is
deemed to be a potential aetiological factor of GLM. The
range of the correlation between GLM and OCS is re-
ported as 0e42%.22,23 In addition to AAT and OCS, a
recent progress in the considerable studies is that smok-
ing is related to theGLM,while an explicit reason has not
yet been determined. Asoglu et al24 presented that in a
research with 18 GLM cases, 14 had a smoking history.
According to a study by Baslaim et al,22 none of their 20
cases was a smoker nevertheless.
Clinical presentation
The GLM mainly occurs in premenopausal females
shortly after their last childbirth. It is generally emerged
with the clinical symptoms of breast mass, abscess,
inflammation and mammary duct fistula. In addition,
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The mass is hard and oedematous fixed to the skin,
accompanied with an axillary node enlargement and
nipple retraction occasionally, which is radiological and
clinical findings of mimic breast cancer. Aspiration
cytology is characteristic, showing leucocytes, giant
cells, epitheloid cells and macrophages. Some patients
are diagnosed with the abscess as well, which is a kind of
tender breast lump with painful and inflamed overlying
skin. The chronic breast abscess can evolve into fistulae
following as the disease progresses.
Pathologic findings
Granulomatous lobular mastitis is characterized by
non-caseating granulomas concentrated in lobules. The
histopathologic features of GLM are the inflammatory
background and significantly lymphoplasmacytic cells.
Microscopical results presented the existence of
numerous Langhans' giant cells, neutrophil poly-
morphs and epithelioid histiocytes in the granulomas.
Besides, microabscesses, necrosis, sinus tracts, duct
ectasia were also observed frequently.25 Gram stains
and microbial cultures of these samples are often
negative in GLM cases, in some degree due to the
fastidious nature of the organisms.
Differential diagnosis
Granulomatous lobular mastitis closely resembles
the duct ectasia/periductal mastitis complex (DE/
PDM) and tuberculous mastitis in the clinical mani-
festations and imaging examination.
The clinical manifestation of tuberculous mastitis
resembles GLM, such as breast lumps, abscess forma-
tion and draining sinuses. Most of tuberculous mastitis
patients do not have systemic symptoms, such as fever
and weight loss,26 and the aspiration cytology, tubercu-
lin test and pathology examination of tuberculous
mastitis can be even negative results, and sometime the
Polymerase Chain Reaction molecular detection tech-
niques is required in the meanwhile.27 However,
compared with GLM, patients with tuberculous mastitis
are younger and have wider lesion range,28 and the main
pathological characteristics are caseation necrosis, with
the incidence of caseation necrosis in tuberculous
mastitis is over 90%, whereas in GLM it is 10%.29
The DE/PDM is another nonpuerperal mastitis,
which principally affect the major breast ducts. The
pathogenesis of DE/PDM have yet to be elucidated, but
in some studies, it is shown to be concerned with
stimulation of squamous epithelium cornification,infections and smoking.25,30 The DE/PDM closely re-
sembles granulomatous lobular mastitis in the clinical
manifestations and imaging examination, but when
compared with GLM, more patients with DE/PDM are
with nipple discharge and nipple retraction, and the
breast masses are often beneath the areola.4,25,30 The
typical pathological characteristics are duct ectatic
which is closest to the nipple, while foam cells and
deciduous ductal epithelial cells exist commonly.
Diffuse plasma cells infiltration, sometime even
foreign body granuloma can be discovered around the
ducts and lobules.4
Granulomatous lobular mastitis is also needed to be
differentiated from sarcoidosis of the breast, foreign
body granuloma, hidradenitis suppurativa and so on, in
which systemic symptoms are apparent.
Treatment
No standard treatment exists for GLM. Observa-
tional management, surgical intervention and medica-
tion treatment (mainly to corticosteroids and
immunosuppressive) are the general therapy method.
Observational management
Literature reports that GLM can be self-limiting
with 6e12 months natural course to stable no matter
what treatment had been taken, and more than half of
GLM patients who do not receive any treatment
revealed complete remission.6,31 Therefore the obser-
vational management is acceptable.
Surgical intervention
Surgical intervention is commonly used in present
clinical practice, but it should be used with caution for
16%e50% recurrence rate was reported after surgical
treatment,27 and this can be related to the scope of
surgical resection. To decrease recurrence rate, the
negative surgical margins of inflammatory tissue must
be achieved. While surgical intervention may also
cause complications such as poor wound healing,
chronic sinus formation and shape change of breast.
For severe and intractable cases, mastectomy followed
by breast reconstruction can be applied as a therapeutic
option after discreet consideration.
Corticosteroids and immunosuppressive agents
Corticosteroids have been used as an conservative
management, which have been reported can decrease
the mass dimension as primary treament and also could
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resistant and complicated cases, corticosteroids should
be administered after excision to prevent GLM recur-
rence.32,33 No standard therapeutic dose and course
time of corticosteroids agents, and a daily dose of
0.5e1 mg/kg of prednisone is reported be effective
treatment for GLM,32 however some studies suggest
that high doses of corticosteroids should be continued
until complete resolution.34 However, infectious aeti-
ology and other contraindications of corticosteroids
should be excluded before agents are administered.
Immunosuppressive agents such as methotrexate can
be used as steroid sparing agents for patients with
contraindication of corticosteroids or in relapse cases
after corticosteroid discontinuation,23,35 and reports
have suggest that low-dose corticosteroids together
with methotrexate could be a reasonable option to
decrease the side effects of corticosteroids.
Conclusion
GLM is a rare inflammatory disorder of the breast,
and the pathogenesis of GLM had yet to be elucidated.
GLM is needed to be differentiated from the duct
ectasia/periductal mastitis complex and tuberculous
mastitis. The histologic examination was the key
method in diagnosis of GLM. No standard treatment
exists for GLM. Observational management, surgical
intervention and medication treatment are the general
therapy method. Well-designed studies will be required
in the future.
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